Sio Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001482416

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 · 54 positions · Total reported value $506.72M · Top-10 concentration 47.9% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.6% · 14 new · 12 cut · 19 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -6.4% · vs SPY -8.6% · Prev Value $604.29M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.5% · vs SPY -3.6% · Latest Value $506.72M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Sio Capital Management, LLC disclosed 54 equity positions with a combined reported value of $506.72M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.9% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M). By sector, the heaviest allocations are Health Care 95.9%, Consumer Discretionary 2.8%. Versus the prior quarter, allocation shifted toward Health Care (+9.3pp), Financials (+1.0pp) and away from Industrials (-1.2pp), Other (-2.4pp).

Versus the prior quarter, Sio Capital Management, LLC opened 14 new positions, trimmed 12 and fully exited 19, a turnover rate of 61.6% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q3 2026 were MRK ($21.14M), PFE ($17.11M), REPL ($11.46M).

Of the 19 positions fully exited versus the prior quarter, the largest were COR ($49.12M), TYRA ($22.21M), WAY ($19.01M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • MRK MERCK & CO INC · $21.14M
  • PFE PFIZER INC · $17.11M
  • REPL REPLIMUNE GROUP INC · $11.46M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $10.46M
  • AZN ASTRAZENECA PLC · $9.99M
  • COO COOPER COS INC · $8.93M
  • LQDA LIQUIDIA CORPORATION · $8.53M
  • PTCT PTC THERAPEUTICS INC · $5.37M

Fully Exited (vs previous quarter)

  • COR CENCORA INC · prev qtr: $49.12M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $22.21M
  • WAY WAYSTAR HLDG CORP · prev qtr: $19.01M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $16.86M
  • CCRN CROSS CTRY HEALTHCARE INC · prev qtr: $14.51M
  • ABT ABBOTT LABORATORIES · prev qtr: $11.67M
  • ZBH ZIMMER BIOMET HOLDINGS INC · prev qtr: $11.32M
  • REGN REGENERON PHARMACEUTICALS · prev qtr: $11.22M

Insider Transactions (Form 4)

Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78021 (status: Approved), registered 2013-05-16
  • Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
  • Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: siocapital.com

Portfolio Structure

  • 59 positions · $604.29M reported value (Q2 2026)
  • Top 10 holdings = 48.6% of reported value
  • Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
  • Average position size: $10.24M

Sector Tilt

  • Health Care 86.6%
  • Consumer Discretionary 6.4%
  • Information Technology 3.1%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 95.9%
Financials 1.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.18M $40.24M 7.94%
7.94%
Reduce
2 476.11K $35.66M 7.04%
7.04%
Add
3 671.12K $32.33M 6.38%
6.38%
Add
4 141.00K $23.97M 4.73%
4.73%
Add
5 2.29M $23.30M 4.60%
4.60%
Add
6 145.49K $21.14M 4.17%
4.17%
New
7 500.12K $19.21M 3.79%
3.79%
Add
8 600.00K $17.11M 3.38%
3.38%
New
9 1.23M $15.15M 2.99%
2.99%
Hold
10 356.18K $14.69M 2.90%
2.90%
Reduce
11 9.10M $14.57M 2.88%
2.88%
Reduce
12 268.28K $14.27M 2.82%
2.82%
Reduce
13 3.63M $13.68M 2.70%
2.70%
Add
14 755.49K $13.39M 2.64%
2.64%
Reduce
15 1.01M $12.56M 2.48%
2.48%
Add
16 865.33K $11.46M 2.26%
2.26%
New
17 428.86K $10.70M 2.11%
2.11%
Add
18 146.27K $10.63M 2.10%
2.10%
Add
19 174.31K $10.46M 2.06%
2.06%
New
20 126.34K $10.05M 1.98%
1.98%
Add
21 61.85K $9.99M 1.97%
1.97%
New
22 291.23K $9.79M 1.93%
1.93%
Reduce
23 873.38K $9.76M 1.93%
1.93%
Reduce
24 33.94K $9.22M 1.82%
1.82%
Reduce
25 158.05K $8.93M 1.76%
1.76%
New
26 282.00K $8.53M 1.68%
1.68%
New
27 561.29K $6.90M 1.36%
1.36%
Reduce
28 1.99M $6.07M 1.20%
1.20%
Add
29 3.63M $6.07M 1.20%
1.20%
Add
30 1.28M $5.92M 1.17%
1.17%
Reduce
31 82.90K $5.37M 1.06%
1.06%
New
32 766.36K $5.23M 1.03%
1.03%
New
33 500.00K $5.10M 1.01%
1.01%
New
34 44.70K $4.71M 0.93%
0.93%
New
35 529.15K $4.38M 0.86%
0.86%
New
36 2.00M $4.00M 0.79%
0.79%
Add
37 75.15K $3.74M 0.74%
0.74%
Add
38 657.10K $3.39M 0.67%
0.67%
Add
39 1.08M $2.95M 0.58%
0.58%
Hold
40 548.10K $2.92M 0.57%
0.57%
Add
41 132.10K $2.84M 0.56%
0.56%
Add
42 95.46K $2.57M 0.51%
0.51%
Reduce
43 1.01M $2.50M 0.49%
0.49%
Hold
44 327.24K $1.84M 0.36%
0.36%
Hold
45 481.60K $1.78M 0.35%
0.35%
New
46 184.42K $1.50M 0.30%
0.30%
New
47 152.46K $1.38M 0.27%
0.27%
Hold
48 373.67K $1.22M 0.24%
0.24%
Reduce
49 440.45K $1.12M 0.22%
0.22%
Add
50 904.27K $1.07M 0.21%
0.21%
Hold

FAQ

What did Sio Capital Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Sio Capital Management, LLC reported 54 equity positions worth $506.72M in aggregate; its largest disclosed positions were AVR ($40.24M), GMED ($35.66M), GSK ($32.33M).

How large is Sio Capital Management, LLC's portfolio?

Sio Capital Management, LLC reported $506.72M of long equity holdings across 54 positions as of 2026-Q3. Top-10 holdings account for 47.9% of reported value.

What is Sio Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →